Moderna cuts back on manufacturing; Lilly eyes Mounjaro supply boost; GSK’s shingles vaccine ‘unconstrained’

Endpoints News dug into this week’s earnings calls to gather biopharma manufacturing updates. We found that Moderna is cutting its manufacturing activities, while Amgen provided updates on two facility builds.

Moderna has started downsizing its manufacturing in the third quarter as the Covid-19 pandemic shifts to an epidemic. The company’s…
Click here to view original post